NxStage reveals next-gen hemo, peritoneal dialysis systems

NxStage Medical (NSDQ:NXTM) announced 3 new products in the pipeline for the dialysis-focused device company during a conference call discussing their quarterly earnings last week. Included in the announcements was a next-generation portable hemodialysis system usable at home or in care centers, a new, simplified peritoneal dialysis machine and a critical care system. “In short, these innovations are designed to give patients even more flexibility in meeting their clinical and lifestyle needs and take us into valuable new segments of our market. We expect these innovations to expand our reach to $5 billion in market opportunity and significantly enhance our long-term growth,” CEO Jeff Burbank said during the conference call. The next-generation hemodialysis system will take a pioneering approach to water purification and dialysate, Burbank said on the call. “This new system produces bicarbonate buffered dialysate on demand from tap water at significantly higher flow rates than we offer today, eliminating the need to prepare a batch of dialysate,” Burbank said. Burbank said the system was based around a disposable fluid pathway so cleaning and disinfecting with heat and chemicals would be¬†unnecessary. The new portable system, he said, will also have a touch screen display and other features to improve setup and ease of use. The new system will work as either a home or in-center machine, Burbank said, designed¬†to fit multiple treatment paradigms. Burba...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Dialysis Research & Development NxStage Medical Inc. Outset Medical Source Type: news